Join S-Booster 2019!
We will invite space-based business ideas from the Asia and Oceania regions!The Contest facilitates the realization of each business idea through open innovation with Japanese companies, and also provides financial support, business coaching and other assistances. Promoting Win-Win Business Cooperation Between Asia and Japan!
Samsara Therapeutics has completed a seed financing round in collaboration with Apollo Ventures, a venture capital company and biotech incubator that supports longevity research and treatments for age-related diseases.
Samsara Therapeutics, Inc. (“Samsara,”) a platform biotechnology startup engaged in the discovery and development of compounds that address the primary molecular causes of aging, announced today the closing of a seed financing round. The financing was led by Apollo Ventures, a life sciences venture capital firm and company builder working across Europe and North America.
Additionally, on February 19th, 2019 Nature Communications published a peer-reviewed paper, “The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species” authored by Samsara’s scientific team [1]. The paper demonstrates the capability of the Samsara platform to identify novel MoA geroprotective small molecules that extend healthy lifespan across species and which are protective in mammalian models of disease.
Continue reading “Samsara is Developing Autophagy Boosting Therapies to Combat Aging” »
A way to speed up quantum computer tech progress has arrived from Intel. If you are interested in following the waves and advances in quantum computing, then get familiar with this word trio: Cryogenic Wafer Prober. Before their design, the electrical characterization of qubits was slower than with traditional transistors. Even small subsets of data might take days to collect.
Drug development. Chemistry. Climate change. Financial modeling. Scientists in all areas look forward to more advancements to push quantum computers to the frontlines. Speeding progress could also mean speeding up advancements in science and industry.
“Quantum computing, in essence, is the ultimate in parallel computing, with the potential to tackle problems conventional computers can’t handle,” said Intel.
With the development of deep fakes and social media bots, there’s a concern about the use of AI in crime. This paper by Floridi is a great analysis of the possible problems that may arise. From the above mentioned deep fakes to AI copying someone’s social media account into another media and pretending to be them or the use of AI financial bots to gather insider information to use in financial manipulation.
The last idea reminds of the scenes in Transcendence where the AI Will Caster makes a fortune in the markets.
Artificial intelligence (AI) research and regulation seek to balance the benefits of innovation against any potential harms and disruption. However, one unintended consequence of the recent surge in AI research is the potential re-orientation of AI.
I agree with the need to prepare.
Yea…maybe. We may see a US stock market crash this year. Truth is we are way over do for a market correction and when it does hit, this may cause a major financial crisis and recession in the US and globally. Are you prepared? 🤔
Hands are old news. VR navigation, control and selection is best done with the eyes—at least that’s what HTC Vive is banking on with the upcoming HTC Vive Pro Eye, a VR headset with integrated Tobii eye tracking initially targeting businesses. I tried out a beta version of the feature myself on MLB Home Run Derby VR. It’s still in development and, thus, was a little wonky, but I can’t deny its cool factor.
HTC announced the new headset Tuesday at the CES tech show in Las Vegas. The idea is that by having eye tracking built into the headset, better use cases, such as enhanced training programs, can be introduced. The VR player also says users can expect faster VR interactions and better efficiency in terms of tapping your PC’s CPU and GPU.
Of course, before my peepers could be tracked I needed to calibrate the headset for my special eyes. It was quite simple, after adjusting the interpupillary distance appropriately, the headset had me stare at a blue dot that bounced around my field of view (FOV). The whole thing took less than a minute.
Continue reading “HTC Vive Pro Eye Hands-On: Feeling Powerful With Built-In Tobii Eye Tracking” »
The researchers found that people have a moral preference for supporting good causes and not wanting to support harmful or bad causes. However, depending on the strength of the monetary incentive, people will at one point switch to selfish behavior. When the authors reduced the excitability of the rTPJ using electromagnetic stimulation, the participants’ moral behavior remained more stable.
“If we don’t let the brain deliberate on conflicting moral and monetary values, people are more likely to stick to their moral convictions and aren’t swayed, even by high financial incentives,” explains Christian Ruff. According to the neuroeconomist, this is a remarkable finding, since: “In principle, it’s also conceivable that people are intuitively guided by financial interests and only take the altruistic path as a result of their deliberations.”
Our actions are guided by moral values. However, monetary incentives can get in the way of our good intentions. Neuroeconomists at the University of Zurich have now investigated in which area of the brain conflicts between moral and material motives are resolved. Their findings reveal that our actions are more social when these deliberations are inhibited.
Continue reading “Morals versus money: How we make social decisions” »
Great news!
Inspired by British billionaire Jim Mellon, chairman of anti-aging upstart biotech venture Juvenescence, Sergey Young unveiled a $100 million fund on Monday to catalyze the development of a comprehensive solution to counteract the damaging consequences of aging.
“I’ve never looked like my age…and with my name, I think it was predetermined that I was going to work in the space (of aging),” Young told Endpoints News. The 47-year-old considers himself a product of Peter Diamandis — the man behind the non-profit XPRIZE and venture capital fund BOLD Capital Partners — and is in charge of all things longevity at both organizations.
Longevity Investor Network member Sebastian Aguiar discusses the rejuvenation biotechnology industry and bridging the gap between research and development.
Sebastian Aguiar is a Venture Fellow at Apollo Ventures, an aging-focused venture capital fund and company builder that invests across Europe and the United States. He can be found at https://www.linkedin.com/in/sebastianaguiar/ and https://twitter.com/sebastian_gero.
What initially attracted you to aging as a general discipline?
Continue reading “Longevity Investor Network Member Spotlight – Sebastian Aguiar” »
